BioCentury
ARTICLE | Clinical News

Xoma preclinical data

June 16, 2008 7:00 AM UTC

In a mouse model of RA, XOMA 052 reduced bone and cartilage destruction caused by collagen-induced arthritis. XOMA 052 also neutralized mouse and human IL-1 beta both in vivo and in vitro. The mAb aga...